DIRECTOR
Joan Guinovart
COLLABORATING INSTITUTIONS
IRB Barcelona
DESCRIPTION
In particular, this study will examine how the ER pathway contributes in leading molecular events in breast cancer metastasis.
Specific objectives:
Objective 1: To characterize novel ER-positive breast cancer metastatic derivatives.
Objective 2: To establish the role of RERG as a metastasis suppressor in ER-positive breast cancer.
Objective 3: To test the hypothesis that ER status influences the choice of metastatic rnechanisrns.